Variant report
Variant | esv3370238 |
---|---|
Chromosome Location | chr1:215006479-215008777 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr1:214999141..215002112-chr1:215005373..215009068,3 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs137975933 | chr1:215006492-215006493 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs552571573 | chr1:215006514-215006515 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs183114843 | chr1:215006518-215006519 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs114542132 | chr1:215006552-215006553 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs142574111 | chr1:215006568-215006569 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs576840678 | chr1:215006576-215006577 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs115109011 | chr1:215006654-215006655 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs541162349 | chr1:215006663-215006664 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs187999893 | chr1:215006667-215006668 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs192618569 | chr1:215006745-215006746 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs570768539 | chr1:215006824-215006825 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs539758941 | chr1:215006837-215006838 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs558109621 | chr1:215006838-215006839 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs554375720 | chr1:215006874-215006875 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs574327232 | chr1:215006884-215006885 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs367617275 | chr1:215006922-215006923 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs11587867 | chr1:215006939-215006940 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs554414613 | chr1:215007009-215007010 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs9429920 | chr1:215007029-215007030 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs527684070 | chr1:215007079-215007080 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs544115042 | chr1:215007104-215007105 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs540016348 | chr1:215007157-215007158 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs554026397 | chr1:215007160-215007161 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs577642275 | chr1:215007193-215007194 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs368828884 | chr1:215007226-215007227 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs143931420 | chr1:215007234-215007235 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs545521825 | chr1:215007244-215007245 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs546145484 | chr1:215007284-215007285 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs182261528 | chr1:215007287-215007288 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs562853466 | chr1:215007316-215007317 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs531646573 | chr1:215007329-215007330 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs376609291 | chr1:215007333-215007334 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs369283327 | chr1:215007338-215007339 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs546394913 | chr1:215007343-215007344 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs12140233 | chr1:215007384-215007385 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs12139434 | chr1:215007390-215007391 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs375742562 | chr1:215007396-215007397 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs529234417 | chr1:215007400-215007401 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs372700547 | chr1:215007404-215007405 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs375788731 | chr1:215007405-215007406 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs369941792 | chr1:215007407-215007408 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs373095707 | chr1:215007410-215007411 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs559941015 | chr1:215007411-215007412 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs376315621 | chr1:215007416-215007417 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs372867052 | chr1:215007418-215007419 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs376894994 | chr1:215007419-215007420 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs370267833 | chr1:215007424-215007425 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs374469660 | chr1:215007430-215007431 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs376939387 | chr1:215007431-215007432 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs371435025 | chr1:215007432-215007433 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Breast cancer | 17603634 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Schizophrenia | 19415332 | CNVD |
Autism | 22495311 | CNVD |
Melanoma | 18172304 | CNVD |
Rett syndrome | 21593744 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 17133270 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Cervical cancer | 21063398 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 20632083 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Medulloblastoma | 21292688 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 21264507 | CNVD |
Liposarcoma | 21253554 | CNVD |
Multiple myeloma | 21628407 | CNVD |
Cancer | 16751803 | CNVD |
Prostate cancer | 16705090 | CNVD |
Neuroblastoma | 19435921 | CNVD |
Breast cancer | 17850661 | CNVD |
Breast cancer | 16461572 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Breast cancer | 21858162 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Breast cancer | 16608533 | CNVD |
Ewing''s sarcoma | 22429812 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 17001317 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Prostate cancer | 18632612 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Ependymoma | 18628472 | CNVD |
Leukemia | 18628472 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Acute lymphoblastic leukemia | 19100363 | CNVD |
Breast cancer | 21509527 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Chordoma | 18071362 | CNVD |
Multiple myeloma | 16461302 | CNVD |
van der Woude syndrome | 22470819 | CNVD |
van der Woude syndrome | 20818247 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Urothelial tumor | 18831757 | CNVD |
Lung cancer | 18438408 | CNVD |
Ovarian cancer | 21720365 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Ovarian clear cell carcinoma | 19293255 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Holoprosencephaly | 19184110 | CNVD |
Breast cancer | 21069454 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Mental retardation | 19951919 | CNVD |
Non-syndromic sensorineural hearing loss | 17873649 | CNVD |
Acute myeloid leukemia | 17268525 | CNVD |
Lung cancer | 16740712 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr1:215002000-215019600 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
2 | chr1:215004800-215007200 | Enhancers | HepG2 | liver |
3 | chr1:215005800-215007200 | Enhancers | NHDF-Ad | bronchial |
4 | chr1:215006000-215007200 | Enhancers | Osteobl | bone |
5 | chr1:215006000-215007400 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
6 | chr1:215006200-215007200 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
7 | chr1:215006200-215007400 | Enhancers | Muscle Satellite Cultured Cells | -- |
8 | chr1:215006400-215007200 | Enhancers | Foreskin Fibroblast Primary Cells skin01 | Skin |
9 | chr1:215006400-215007200 | Enhancers | NH-A | brain |
10 | chr1:215007000-215009200 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
11 | chr1:215007200-215010400 | Weak transcription | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
12 | chr1:215007200-215010400 | Weak transcription | NHDF-Ad | bronchial |
13 | chr1:215007200-215010600 | Weak transcription | Osteobl | bone |
14 | chr1:215007200-215010800 | Weak transcription | NH-A | brain |
15 | chr1:215007200-215011000 | Weak transcription | Foreskin Fibroblast Primary Cells skin01 | Skin |
16 | chr1:215007400-215007800 | Weak transcription | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
17 | chr1:215007400-215011000 | Weak transcription | Muscle Satellite Cultured Cells | -- |
18 | chr1:215007800-215008000 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
19 | chr1:215007800-215008800 | Enhancers | Adipose Nuclei | Adipose |
20 | chr1:215008000-215011400 | Weak transcription | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |